Quick Links

 K.K. Wong, M.D.

  • Professor, Virology
  • Member, Hematologic Malignancies Program, Comprehensive Cancer Center
  • Professor of Hematology/HCT

Dr. K.K. Wong and his staff are working toward rAAV vector improvement. One of the lab’s goals is to develop strategies to exploit the ability of AAV to integrate site-specifically into the human genome to increase the safety and efficacy of gene transfer. In addition, the lab develops tumor-specific vaccines using rAAV vectors and rAAV vectors to protect cells from targeted pathogenic viruses.

Professional Experience

1991 - present, City of Hope Committees: Member, Cancer Center, IRB (1996); Vice Chair Institutional Biosafety Committee (IBC) (2003-present)

1991 - present, Staff Physician, Department of Hematology, Hematopoietic Cell Transplantation Service; Professor, Department of Virology, City of Hope, Duarte, CA

1990 - 1991, Senior Staff Fellow, Molecular Structure Section, Laboratory of Viral Diseases, NIAID, National Institutes of Health, Bethesda, MD

1984 - 1990, Medical Staff Fellow, Molecular Structure Section, Laboratory of Viral Diseases, NIAID, National Institutes of Health, Bethesda, MD

1983 - 1984, Instructor in Pathophysiology of Infectious Diseases, Harvard Medical School

1981 - 1984, Research Fellow in Medicine, Harvard Medical School, Boston, MA

1981 - 1984, Clinical and Research Fellow in Medicine, Massachusetts General Hospital

1979 - 1981, Clinical and Research Fellow in Hematology-Oncology, University of Chicago Hospitals and Clinics, Chicago, IL

1976 - 1979, Intern and Resident, Osler Medical Service, Johns Hopkins Hospital, Baltimore, MD

Education and Training

1976, Columbia University, College of Physicians and Surgeons, New York, NY , M.D., Medicine

1974, Johns Hopkins University, Baltimore, MD, B.A., Natural Sciences

Board Certifications

1986, Board Certified, Infectious Diseases

1983,
Board Certified, Medical Oncology

1980, Board Certified, Internal Medicine

This is an abbreviated document. Full CV available upon request. Information on this page may be self-reported and subject to change at any time. Last updated 10/08.

K.K. Wong, M.D.

Honors and Awards

2005 - present, Reviewer, NIH HIV Vaccines ZRG1 VACC 017 Study Section

2004 - 2005, Reviewer (Meeting Abstracts), American Society of Gene Therapy

2003 - present, Scientific Review Board, National Gene Vector Labs (NGVL/NIH)

2000 - 2005, Ad hoc reviewer, NHLBI Gene Therapy Programs in Excellence

1999, Ad hoc reviewer, NIAID Recombinant HIV Vaccine grant proposals

1998, Ad hoc reviewer, NIH-SBIR grant proposals

1998, Reviewer, American Society of Hematology (ASH), Meeting Abstracts

1997, Reviewer, American Society of Hematology (ASH), Meeting Abstracts

1996, Reviewer, American Society of Hematology (ASH), Meeting Abstracts

1995 - 1996, Ad hoc reviewer, Gene Therapy Program NIDDK

1975, Elected Alpha Omega Alpha (National Medical Honor Society)

Manuscript Reviewer: Blood, Molecular Therapy, Cancer Research, Leukemia, J Virol, Current Gene Therapy, Human Gene Therapy, Cancer Gene Therapy

PATENTS
5,474,935: rAAV Vectors
6,919,209: Genetic Modification of Quiescent Stem Cells

 Search

Go!
Advanced Search Options
News & Publications Search

 Contact Information

To reach me or my staff,
call 626-256-HOPE (4673).

 Learn More

NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.